REGULATORY

Relief Claims OK’ed for 12 More Deaths Possibly Linked to COVID Jabs

April 18, 2023

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

A Japanese health ministry panel that reviews claims for post-immunization health damages on April 17 determined 12 additional deaths as being possibly associated with COVID-19 vaccinations, bringing the total number of such mortality cases to 53. The reasonably possible link…

To read the full story

MHLW Panel OKs 192 More Health Damage Claims for COVID-19 Vaccines
April 24, 2023
MHLW Panel OKs 184 More Health Damage Claims for COVID-19 Jabs
March 22, 2023
Japan Damage Relief Panel Recognizes 11 More Deaths Possibly Tied to COVID Jabs
March 16, 2023
Japan Panel Recognizes 10 More Deaths Possibly Linked to COVID Jabs
February 13, 2023
MHLW Panel OKs 79 More Health Damage Claims for COVID-19 Vaccines
February 8, 2023
MHLW Panel OKs 62 More Health Damage Claims for COVID-19 Vaccines
January 24, 2023
MHLW Panel OKs 64 More Health Damage Claims for COVID-19 Vaccines
January 16, 2023
Japan Panel Recognizes 5 More Deaths Possibly Tied to COVID Vaccines
January 13, 2023
Japan to Boost Review of Health Damage Claims for COVID-19 Vaccines
January 12, 2023
MHLW Panel OKs 70 More Health Damage Claims for COVID-19 Vaccines
December 26, 2022
Japan Panel Recognizes 5 More Deaths Possibly Linked to COVID Jabs, 1st for 20s
December 13, 2022
MHLW Panel OKs 111 More Health Damage Claims for COVID-19 Vaccines
November 28, 2022
2 Women Die after BA.5 COVID Booster Shots: MHLW
November 14, 2022
Japan Panel Recognizes 6 More Deaths Possibly Linked to COVID Vaccines
November 8, 2022
MHLW Panel OKs 100 More Health Damage Claims for COVID-19 Vaccines
October 31, 2022
Japan Panel Recognizes One More Death Possibly Linked to COVID Jab
October 18, 2022
MHLW Panel OKs 65 More Health Damage Claims for COVID-19 Vaccines
September 26, 2022
MHLW Panel Recognizes 2 More Deaths Linked to COVID Jabs
September 13, 2022
MHLW Panel OKs 60 More Health Damage Claims for COVID-19 Vaccines
July 29, 2022
Japan Panel Recognizes 1st Death Linked to COVID Vaccination
July 26, 2022
MHLW Panel OKs 56 More Health Damage Claims for COVID-19 Vaccines
June 27, 2022
MHLW Panel OKs 62 More Health Damage Claims for COVID-19 Vaccines
June 3, 2022
MHLW Panel OKs 84 More Health Damage Claims for COVID-19 Vaccines
March 28, 2022
MHLW OKs 48 More Health Damage Claims for COVID-19 Vaccines
February 28, 2022
MHLW OKs 115 More COVID-19 Vaccine Health Damage Claims
February 1, 2022
MHLW Panel OKs 81 More COVID-19 Vaccine Health Damage Claims
October 25, 2021
Panel OKs 37 More COVID-19 Jab Health Damage Claims for Compensation
September 14, 2021
Japan Panel OKs COVID-19 Vaccine Health Damage Claims for First Time
August 20, 2021

REGULATORY

MHLW Revises Biological Raw Material Rules, Clarifies Donor Testing Flexibility
April 2, 2026
Japan Officially Eases Trial Recruitment Rules; Industry Welcomes Move
April 1, 2026
MHLW Updates Q&A on Use of Registry Data in Drug Applications
April 1, 2026
Japan Panel Designates Two Ebola Therapies for Early Approval Pathway
April 1, 2026
MHLW, METI Launch Joint Task Force to Safeguard Medical Supply Chains
April 1, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…